There are also significant increases in the percentage of circulating monocytes (CD45+CD11b+Ly6Chi), CD4 T-cells (CD45+CD4+CD8−), and CD8 T-cells (CD45+CD8+CD4−) out of CD45+ cells in the tumour-bearing mice with E2V. Here, PTPRC is linked to neoplasm.